Incanthera plc – Corporate Update & Board Changes
ImmuPharma PLC has noted an announcement from Incanthera plc regarding corporate updates and board changes, specifically that Tim McCarthy has stepped down as Executive Chairman of Incanthera. This development is the primary focus of the announcement, with no other financial figures or operational details provided by ImmuPharma in this RNS.
Select text to share a quote on X · sign in to keep highlights & notes in your IMM notes
ImmuPharma plc (LSE AIM: IMM), the specialist drug discovery and development company, notes today's announcement by Incanthera plc, "Incanthera", regarding a corporate update and subsequent Board changes. As part of the Board changes, Tim McCarthy has stepped down as Executive Chairman of Incanthera: Link: https://incanthera.com/ news-media/.
ImmuPharma PLC (www.immupharma.co.uk.)
Tim McCarthy, Chief Executive Officer and Chairman
| Lisa Baderoon, Head of Investor Relations | + 44 (0) 7721 413496 |
| SPARK Advisory Partners Limited (NOMAD) Neil Baldwin Stanford Capital Partners (Joint Broker) Patrick Claridge, Bob Pountney SI Capital (Joint Broker) Nick Emerson | +44 (0) 203 36 8 8974 +44 (0) 203 650 3650 +44 (0) 1483 413500 |
About Reach announcements
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.